Lee Ki-Hwan, Chang Mi-Yoon, Ahn Joon-Ik, Yu Dong-Hyun, Jung Sung-Soo, Choi Jung-Hye, Noh Yun-Hee, Lee Yong-Sung, Ahn Myung-Ju
Department of Biochemistry, College of Medicine, Hanyang University, Seoul, Republic of Korea.
Biochem Biophys Res Commun. 2002 Sep 6;296(5):1125-33. doi: 10.1016/s0006-291x(02)02043-0.
Acute promyelocytic leukemia (APL) is characterized by a specific chromosome translocation t(15;17), which results in the fusion of the promyelocytic leukemia gene (PML) and retinoic acid receptor alpha gene (RARalpha). APL can be effectively treated with the cell differentiation inducer all-trans retinoic acid (ATRA). NB4 cells, an acute promyelocytic leukemia cell line, have the t(15;17) translocation and differentiate in response to ATRA, whereas HL-60 cells lack this chromosomal translocation, even after differentiation by ATRA. To identify changes in the gene expression patterns of promyelocytic leukemia cells during differentiation, we compared the gene expression profiles in NB4 and HL-60 cells with and without ATRA treatment using a cDNA microarray containing 10,000 human genes. NB4 and HL-60 cells were treated with ATRA (10(-6)M) and total RNA was extracted at various time points (3, 8, 12, 24, and 48h). Cell differentiation was evaluated for cell morphology changes and CD11b expression. PML/RARalpha degradation was studied by indirect immunofluoresence with polyclonal PML antibodies. Typical morphologic and immunophenotypic changes after ATRA treatment were observed both in NB4 and HL-60 cells. The cDNA microarray identified 119 genes that were up-regulated and 17 genes that were down-regulated in NB4 cells, while 35 genes were up-regulated and 36 genes were down-regulated in HL60 cells. Interestingly, we did not find any common gene expression profiles regulated by ATRA in NB4 and HL-60 cells, even though the granulocytic differentiation induced by ATRA was observed in both cell lines. These findings suggest that the molecular mechanisms and genes involved in ATRA-induced differentiation of APL cells may be different and cell type specific. Further studies will be needed to define the important molecular pathways involved in granulocytic differentiation by ATRA in APL cells.
急性早幼粒细胞白血病(APL)的特征是特定的染色体易位t(15;17),这导致早幼粒细胞白血病基因(PML)与维甲酸受体α基因(RARα)融合。APL可用细胞分化诱导剂全反式维甲酸(ATRA)有效治疗。NB4细胞是一种急性早幼粒细胞白血病细胞系,具有t(15;17)易位,并对ATRA产生反应而分化,而HL-60细胞即使在经ATRA诱导分化后仍缺乏这种染色体易位。为了确定早幼粒细胞白血病细胞在分化过程中基因表达模式的变化,我们使用包含10000个人类基因的cDNA微阵列,比较了经ATRA处理和未经处理的NB4和HL-60细胞的基因表达谱。用ATRA(10(-6)M)处理NB4和HL-60细胞,并在不同时间点(3、8、12、24和48小时)提取总RNA。通过细胞形态变化和CD11b表达评估细胞分化。用多克隆PML抗体通过间接免疫荧光研究PML/RARα降解。在NB4和HL-60细胞中均观察到ATRA处理后典型的形态学和免疫表型变化。cDNA微阵列鉴定出在NB4细胞中有119个基因上调,17个基因下调,而在HL60细胞中有35个基因上调,36个基因下调。有趣的是,尽管在两种细胞系中均观察到ATRA诱导的粒细胞分化,但我们未在NB4和HL-60细胞中发现任何受ATRA调节的共同基因表达谱。这些发现表明,参与ATRA诱导APL细胞分化的分子机制和基因可能不同且具有细胞类型特异性。需要进一步研究以确定ATRA诱导APL细胞粒细胞分化所涉及的重要分子途径。